When assessing the differences, it was observed that in SCLC patients, RB1 was depicted with a higher number of different mutations and this gene was altered in a higher number of patients (in tumors), while in blood samples, RET, ATM, and ABL1 appeared altered only in the SCLC group. The gene discussed is RET; the disease is small cell lung carcinoma.